CORE SCIENTIFIC INC

Core Scientific’s insider sale shows a disciplined exit, strong tech, weak earnings – keep an eye on earnings, strategy and market sentiment to gauge future value.

Insider selling spurs debate: Core Scientific’s CFO sells 10,000 shares as executives re‑balance, hinting at confidence yet cautioning investors on valuation risks.

Weiss Eric Stanton buys 6,000 shares of Core Scientific, signaling steady insider confidence in the company’s AI‑driven infrastructure pivot and potential upside for investors.

Inside Core Scientific’s planned insider sales: Todd Duchene’s Rule 10b‑5‑1 strategy shows disciplined liquidity, not panic, while the company’s AI‑powered blockchain tech keeps upside potential high for long‑term investors.